For more than a century, the drug industry has issued dire warnings of plunging innovation whenever regulation reared its ...
Mortality rose with body mass index in patients with new atrial fibrillation in a GARFIELD-AF analysis, which also examined ...
Discovery follows a report of a man in Rockland County stricken with polio and paralyzed. The last case of polio in the US ...
Angelo Falcone, MD, a former emergency physician in Rockville, Maryland, found that a private equity investment transformed ...
Atypical presentations are common in the current monkeypox outbreak. This factor may contribute to missed diagnoses and an ...
Two children have died 5-6 weeks after infusion with the gene therapy drug onasemnogene abeparvovec (Zolgensma), a treatment ...
Approved in the US last year, efgartigimod (Vyvgart) is a first-in-class targeted therapy for patients with generalized ...
Regular smokers in Denmark purchased fewer cigarettes during the initial phase of the COVID-19 pandemic than they had ...
Medscape's Physician Wealth & Debt Report 2022 looked at physicians' finances in detail. Here are some stories that ...
Xylazine, an animal tranquilizer, has made it into the illegal drug supply of opioids and cocaine. It is changing the way ...
While switches between biosimilars of the same reference biologic already occur for biosimilars with indications in different specialties, they do not meet regulators' interchangeability standards.
An antiviral medication that's been treating adults with influenza for years now has an application for children.